chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US099925 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531815) on 08 Aug 2014. This report refers to a 12 years old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: M12100) intramuscularly in the right arm on 31 Jan 2014. It was reported that the vaccine administration to him experienced temperature excursion. No adverse event was reported following the medication error.
Age: 16.0
Sex: F
Vaccine: IPV, MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US099926 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531816) on 08 Aug 2014. This report refers to a 16 years old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: M12102) intramuscular in the right arm and IPOL (other manufacturer, batch number: J13821) subcutaneously into left arm, both on 24 Jan 2014. It was reported that both the vaccines administered to her experienced temperature excursion. No adverse event was reported following this medication error.
Age: 16.0
Sex: F
Vaccine: IPV, MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100171, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531818) website on 08 Aug 2014. This report refers to an 16 year old female patient. Her past medical history and concomitant medications were not reported. On 22 Jan 2014, she was vaccinated with MENVEO (batch number: M12102) intramuscularly into her right arm and IPOL (other manufacturer, batch number: J13821) subcutaneously into her left arm which had temperature excursions while in storage. No adverse events were reported following this medication error.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100184, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531843) website on 08 Aug 2014. This report refers to a 15 year old female patient. Her past medical history and concomitant medications were not reported. On 24 Jan 2014, she was vaccinated intramuscularly into her left arm with MENVEO (batch number: M121012) which had a temperature excursion while in storage. No adverse events were reporting following this medication error.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100186, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531844) website on 08 Aug 2014. This report refers to a 17 year old female patient. Her past medical history and concomitant medications were not reported. On 24 Jan 2014, she was vaccinated intramuscularly into her left arm with MENVEO (batch number: M12102) which had a temperature excursion while in storage. No adverse events were reporting following this medication error.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100191, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531855) website on 08 Aug 2014. This report refers to a 16 year old male patient. His past medical history and concomitant medications were not reported. On 03 Feb 2014, he was vaccinated intramuscularly into his left arm with MENVEO (batch number: M12100) which had a temperature excursion while in storage. No adverse events were reported following this medication error.
Age: 14.0
Sex: F
Vaccine: IPV, MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100195, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531858) website on 08 AUG 2014. This report refers to a 14 year old female patient,. Her past medical history and concomitant medications were not reported. On 25 FEB 2014, she was vaccinated with MENVEO (batch number: U4556AB) intramuscularly into her right arm which had a temperature excursion while in storage and IPOL (other manufacturer, batch number: J13821) subcutaneously into her left arm. No adverse events were reported following this maladministration (incorrect storage of drug).
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100814, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531861) web site on 08 AUG 2014. The report refers to a 11 year old male patient. His past medical history and concomitant medications were not reported. On 29 JAN 2014, he was vaccinated intramuscularly into his right arm with MENVEO (batch number: M12102) which had a temperature excursion while in storage. No adverse events were reported following this medication error (incorrect storage of drug).
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100821, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 531866) website on 08 AUG 2014. This report refers to an 11 year old male patient. His past medical history and concomitant medications were not reported. On 03 FEB 2014, he was vaccinated intramuscularly into his right arm with MENVEO (batch number: M12100) which had a temperature excursion while in storage. No adverse events were reported following this medication error (incorrect storage of drug).
Age: 11.0
Sex: M
Vaccine: IPV, MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100486, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531935) website on 08 AUG 2014. This report refers to an 11-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: M12102) intramuscularly into right arm along with IPOL (batch number: J13821) subcutaneously into left arm on 27 JAn 2014. It was reported that there was a temperature excursions of MENVEO vaccine No adverse event was reported following this medication error (incorrect storage of drug).
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US099527, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531938) website on 08 AUG 2014. This report refers to an 18 year old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: M12100) intramuscularly into left arm on 30 JAN 2014. It was reported that there was a temperature excursion of vaccine. Before administration it was not store din recommended temperature range. No adverse event was reported following the medication  error (incorrect  storage of drug)
Age: 32.0
Sex: M
Vaccine: HEPA, IPV, MNQ, YF
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Pyrexia
Clinical narrative: Case number PHHY2014US099604, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531973) website on 08 AUG 2014. This report refers to a 32-year-old male patient. He had no know drug allergies. He was vaccinated with  MENVEO (batch number: A13046) into right arm on 19 MAY 2014. On the same day, he was also vaccinated with HAVRIX (batch number: 59D74, other manufacturer) into left arm, IPOL (batch number: J1406, other manufacturer) into right arm and YF-VAX (batch number UH858AA) into left arm. Late that evening the injection site area became red, swollen and itchy. He also developed a fever of 102 degrees Fahrenheit. He had a visit to physician on 22 MAY 2014 and was feeling better and afebrile. He revisited physician on 23 MAY 2014 to have redness on his arm assessed. Final outcome of the events was reported as recovered. These events were reported as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100639 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531059) on 08 AUG 2014. This report refers to an 11 years old male patient. His medical history and concomitant medication were not reported. He was vaccine with MENVEO (batch number: M12100) intramuscularly in the left arm on 10 FEB 2014. it was reported that the vaccine administered to him experienced temperature excursion. No adverse event was reported following the medication error (incorrect storage of drug).
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100640 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 532066) on 08 AUG 2014. This report refers to a 17 years old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number M12100) intramuscularly in the left arm on 13 JAN 2014. It was reported that the vaccine administered to him experienced temperature excursion. No adverse event was reported following the medication error (incorrect storage of drug).
Age: 28.0
Sex: F
Vaccine: HEP, MMR, MNQ
Symptoms: Paraesthesia oral, Pruritus, Urticaria
Clinical narrative: Case number PHHY2014US100541, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 532252) website on 08 AUG 2014. This report refers to a 28-year-old female patient. Past medical history included allergies to penicillin, sulfa, rocephin, shellfish and green peppers. No concomitant medication was reported. Vaccination history included administration of unspecified vaccine (vaccine not specified) and experienced rash during child hood and history of childhood immunization. She was vaccinated with MENVEO (batch number: A13047) intramuscularly into the right arm long with ENGERIX-B (batch number: 99B32) intramuscularly into the left arm and MMR II (batch number: J006995) subcutaneously into the right arm on 22 MAY 2014. The vaccines were administered minutes apart. The last vaccine administered was MMR. On the same day approximately two minutes after vaccination, she experienced itching and hives noted to neck and below hairline to back of neck. She also experienced lips tingling. She was sent to emergency room and continued hives were noted. It was reported that anaphylaxis protocol per policy was followed in emergency room by the physician. The final outcome of the events was complete recovery. The events were reported as non-serious, however, the case was internally upgraded as medically significant by the MAH. Causality was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2014US100636, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531274) website on 08 AUG 2014. This report refers to an 18-year-old female patient. Historical conditions were none. No concomitant medication was reported. She was vaccinated with MENVEO (batch number: x13015/A13015) intramuscularly into the left arm on 15 MAY 2014. On 16 MAY 2014, she experienced low Grade fever of 100.8 degrees Fahrenheit. The final outcome of the event was complete recovery on own. The event was reported as non-serious. Causality was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site induration, Injection site pain
Clinical narrative: Case number PHHY2014US100658, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 532362) website on 08 AUG 2014. This report refers to an 11-year-old male patient. Past medical history included mild dust allergy. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: M13012) intramuscularly into the right arm deltoid region on 27 MAY 2014. On 28 MAY 2014, he developed pain, tenderness and induration (12) which progressed in 24 hours in right arm deltoid region. He had no fever and no other constitutional lymph. The events started improving in 48 hrs. The event was reported as non-serious. Causality was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site inflammation, Injection site warmth
Clinical narrative: Case number PHHY2014US101334, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 532394) website on 08 AUG 2014. This report refers to an 11-year-old female patient. Historial conditions were not reported. No concomitant medication was reported. She was vaccinated with MENVEO, (batch number: not reported) along with BOOSTRIX (batch number: CN532) intramuscularly on 21 MAY 2014. On 22 MAY 2014 at 07:00 AM, 22 hours after injection, she experienced redness, heat with inflammation at injection site. The final outcome of the events was complete recovery. The events were reported as non-serious. Causality was not reported.
Age: 6.0
Sex: F
Vaccine: MNQ
Symptoms: Exposure during pregnancy, Human chorionic gonadotropin, No adverse event, Pregnancy test urine
Clinical narrative: Case number PHHY2014US101355., is an initial spontaneous report received from a nurse via Vaccine Adverse Event Reporting System (VAERS reference number: 532405) website on 08 AUG 2014 with a follow up information received on 05 MAR 2015. This report refers to a 16-years-old female patient. She was on no other medications. Her last menstrual period (LMP) was around 15 MAR 2014. She was vaccinated with MENVEO (batch number: not reported) on 14 MAY 2014. On unspecified dates she was vaccinated with the first and second dose of GARDASIL (batch number: not reported). On an unknown date she received third dose of GARDASIL (batch number: not reported) intramuscularly at a dose of 0.5 ml. Her estimated date of delivery (EDD) was 20 DEC 2014. There was no adverse effect reported and no product quality complaint (PQC) involved. Urine test and Human Chorionic Gonadotropin (HCG) test for pregnancy were performed and the results were not provided. Gravida, para, date of conception, foetus demographics were not provided. Upon follow up information received on 05 MAR 2016, it was reported that the reporter was anonymous and therefore no additional follow up could be pursued. The case was considered as lost to follow up. Follow up information received on 05 MAR 2015: Lost to follow up information was updated.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100826, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 532511) website on 08 AUG 2014. This report refers to a 16 year old male patient. His past medical history and concomitant medications were not reported. On 26 FEB 2014, he was vaccinated intramuscularly into his left arm with MENVEO, batch number: U4556AB) which had a temperature excursion while in storage. No adverse events were reported following this medication error (incorrect storage of drug).
Age: 16.0
Sex: F
Vaccine: IPV, MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100829, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 532512) website on 08 AUG 2014. This report refers to a 16 year old female patient. Her past medical history and concomitant medications were not reported. On 03 FEB 2014, she was vaccinated intramuscularly into her right arm with MENVEO (batch number: M12100) which had a temperature excursion while in storage and with the fourth dose of IPOL (other manufacturer, batch number: J13821) subcutaneously into her left arm. No adverse events were reported following this medication error (incorrect storage of drug).
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US100830, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 532525) website on 08 AUG 2014. This report refers to a 12 year old female patient. Her past medical history and concomitant medications were not reported. On 07 MAR 2014, she was vaccinated intramuscularly into her right arm with MENVEO (batch number: M13017) which had a temperature excursion while in storage. No adverse events were reported following this medication error (incorrect storage of drug).
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHHY2014US103292 is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 532555) website on 08 AUG 2014. This report refers to a 15 year old male patient. His past medical history and concomitant medications were not reported. On 23 JAN 2014, he was vaccinated  intramuscularly into his left arm with MENVEO (batch number: M12102) which has a temperature excursion while in storage. No adverse events were reported following this medication error (incorrect storage of drug).
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Contusion, Haematoma, Inflammation
Clinical narrative: Case number PHHY2014US116450, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 532929) website on 03 SEP 2014. This report refers to an 11-year-old male patient. Concurrent conditions included upper respiratory injection (URI). No concomitant medication was reported. He was vaccinated with MENVEO (batch number: A13017) along with BOOSTRIX (batch number: U4618AA) and GARDASIL (batch number: J013824) on 31 MAY 2014. On the same day after vaccination, he experienced contusion, hematoma and inflammation. The final outcome of the events was complete recovery. The events were reported as non-serious, however, the case was internally upgraded as medically significant by the MAH. Causality was not reported.
Age: 11.0
Sex: F
Vaccine: HEPA, HPVX, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2014US100576, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 532940) website on 08 AUG 2014. This report refers to an 11-year-old female patient. Past medical history included allergic to amoxicillin which caused hives. She was vaccinated with MENVEO (batch number: M13030) intramuscularly into left arm on 28 MAY 2014. On the same day, she was also vaccinated with VAQTA (batch  number: K000578, other manufacturer) intramuscularly into right arm, ADACEL (batch number: U4668AA, other manufacturer) intramuscularly into right arm and HPV (human papilloma virus vaccine, batch number:  unknown). On 29 MAY 2014, one day after vaccinations, she experienced large area of swelling and redness at the injection site. There events were reported as moderate reaction and non-serious. Outcome and causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HPVX, MEN
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Case number PHHY2014US093032 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 532944) website on 22 JUL 2014. This report refers to an 11-year-old female patient. Her medical history included attention deficit hyperactivity disorder (ADHD) and concomitant medications were not reported. She was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported) in the left arm and human papilloma virus vaccine (other manufacturer, batch number: not reported) in the right arm on 03 JUN 2014. On 03 JUN 2014, she had severe swelling in the arm and redness. Her arm was fever (warm) to touch, itchy and painful. It was reported that she also had fever and her side effects were not getting better as of 6 PM on the following day. The final outcome of the event was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: HPVX, MEN
Symptoms: Skin warm
Clinical narrative: Case number PHHY2014US093032 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 532944) website on 22 JUL 2014. This report refers to an 11-year-old female patient. Her medical history included attention deficit hyperactivity disorder (ADHD) and concomitant medications were not reported. She was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported) in the left arm and human papilloma virus vaccine (other manufacturer, batch number: not reported) in the right arm on 03 JUN 2014. On 03 JUN 2014, she had severe swelling in the arm and redness. Her arm was fever (warm) to touch, itchy and painful. It was reported that she also had fever and her side effects were not getting better as of 6 PM on the following day. The final outcome of the event was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Erythema, Induration, Local reaction
Clinical narrative: Case number PHHY2014US111281 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533143) website on 03 SEP 2014. This report refers to an 11 year old male patient.; He had no preexisting medical condition or concomitant medications. He was vaccinated with MENVEO (batch number: M12102) into left arm and GARDASIL (other manufacturer, batch number: J009788) into right arm on 04 JUN 2014. On 05 JUN 2014, he experienced local reaction to immunization, described as erythema at a diameter of 10 cm and a central induration with a diameter of approximately 04 cm in left arm. He did not experience fever. His mother instructed him to do cold compresses. The outcome was reported as condition unchanged. The causality was suspected to immunization. The seriousness was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Urticaria
Clinical narrative: Case number PHHY2014US111354 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number:533197) website on 03 SEP 2014. This report refers to an 11 year old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: M13030) intramuscularly into right arm, GARDASIL (other manufacturer, batch number: J013324) intramuscularly into right arm and ADACEL (other manufacturer, batch number: C4456AA) intramuscularly into left arm on 30 MAY 2014. On 31 MAY 2014, she developed hives on hands and legs. She was taken to emergency room for medical support. She did  not experience respiratory symptoms. The outcome was reported as condition unchanged. The causality and seriousness were not reported.
Age: 25.0
Sex: F
Vaccine: MNQ
Symptoms: Body temperature increased, Injection site erythema, Injection site pruritus, Injection site reaction, Injection site swelling
Clinical narrative: Case number PHHY2014US100654, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 533246) website on 08 AUG 2014. This report refers to a 25-yearold female patient. Past medical history and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M13064) intramuscularly into right arm on 05 JUN 2014. On 06 JUN 2014, one day after vaccination, she experienced redness, swelling, itching and welts/hives at the area of  injection site. She also experienced increase in body temperature. The size of welts increased to 3x4 inches when seen in urgent care on 08 JUN 2014. It was also noted that  there was an increase in itching and body temperature. She was given steroid sot and steroid pack (unspecified), reports better on 09 JUN 2014 at 7:30 PM. The events were reported as non-serious. Causality of the events was not reported.
Age: 25.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: Case number PHHY2014US100654, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 533246) website on 08 AUG 2014. This report refers to a 25-yearold female patient. Past medical history and concomitant medications were not provided. She was vaccinated with MENVEO (batch number: M13064) intramuscularly into right arm on 05 JUN 2014. On 06 JUN 2014, one day after vaccination, she experienced redness, swelling, itching and welts/hives at the area of  injection site. She also experienced increase in body temperature. The size of welts increased to 3x4 inches when seen in urgent care on 08 JUN 2014. It was also noted that  there was an increase in itching and body temperature. She was given steroid sot and steroid pack (unspecified), reports better on 09 JUN 2014 at 7:30 PM. The events were reported as non-serious. Causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Lymphadenopathy, Oedema peripheral, Pain
Clinical narrative: Case number PHHY2014US111587 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533293) website on 03 SEP 2014. This report refers to a 12 year old male patient. His medical history  included fructose malabsorption. His concomitant medications included Miralax, Flonase, Dulera, and Albuterol. He was vaccinated with MENVEO (batch number: A13064) into left arm on 03 JUN 2014. On 04 JUN 2014, he experienced baseball size redness at injection site, pea sized lymph nodes (2 to 3) at left axilla and axilla swelling. He also experienced pain (unspecified) at a pain scale of 9/10. He was taken to emergency room or medical support. Pain lasted for 3 to 4 days. The final outcome was reported as complete recovery. The eevents were reported as non-serious. Causality was not reported.
Age: 17.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Rash, Tenderness
Clinical narrative: Case number PHHY2014US111559, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 533408) website on 03 SEP 2014. This report refers to a 17-year-old female patient. She was diagnosed with mononucleosis in early MAR 2014 and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: M13058) in the left arm and with the fifth dose of BOOSTRIX (other manufacturer, batch number: N59M3) in the left arm on 02 JUN 2014. On 03 JUN 2014, the patient had a rash on trunk, back and some on hands and these bumps described as tender. The outcome of the events reported as complete recovery. The seriousness of the events reported as non-serious. The causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Case number PHHY2014US112600 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533447) website on 03 SEP 2014. This report refers to an 18 year old female patient. She had no medical history or concomitant medications. She was vaccinated with MENVEO (batch number: NORM13047CP) into left arm on 13 MAY 2014. On 14 MAY 2014, her left arm became red, warm and hard jut below shot site. She did not experience fever. Final outcome was reported as complete recovery. The events were reported as non serious. Causality was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Nausea, Petechiae, Pyrexia, Vomiting
Clinical narrative: Case number PHHY2014US116400, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533535) website on 03 SEP 2014. This report refers to a 12-year-old male patient. Past medical history included asthma and allergic rhinitis. No concomitant medication was reported. He was vaccine with MENVEO (batch number: M13030) into the right arm and along with BOOSTRIX (batch number: T25EG) into the left arm intramuscularly on 09 JUN 2014. On 10 JUN 2014, he experienced low grade fever (100.6 orally), petechiae to face (eye area) and neck, nausea and vomiting. He was sent to emergency room. The final outcome of the events were complete recovery. The events were reported as non-serious, however, the case was internally upgraded as medically significant by the MAH. Causality was not reported.
Age: 17.0
Sex: F
Vaccine: FLU3, HPV4, MNQ, TDAP
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Case number PHHY2014US112637 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533537) website on 03 Sep 2014. This report refers to a 17 year old female patient. She had no medical history or concomitant medications. She was vaccinated with MENVEO (batch number: A13017) into right arm, GARDASIL (other manufacturer, batch number: H020901) into right arm, FLUZONE (other manufacturer, batch number: UH921AA) into left arm and ADACEL (other manufacturer, batch number: E5957) into left arm, all via intramuscular route on 10 Jun 2014. On the same day after vaccination, she complained light headedness/dizziness, nausea and one episode of vomiting. Final outcome was reported as complete recovery. The events were reported as non-serious. Causality was not reported.
Age: 10.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Blister, Erythema, Pain, Rash pustular, Swelling
Clinical narrative: Case number PHHY2014US100278, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533552) website on 08 AUG 2014. This report refers to a 10 year old male patient. His medical history include asthma and tinea corporis. On 04 JUN 2014, he was vaccinated with MENVEO (batch number: A13015) along with BOOSTRIX (other manufacturer, batch number: N2K6) both intramuscularly in the right arm. On 05 JUN 2014, in the night he developed redness initially and then small pustules, which progressed to blisters with continuing redness, pain and swelling. The outcome of the events reported as recovered on an unknown date. The events, reported as  non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site warmth, Pain in extremity
Clinical narrative: Case number PHHY2014US115820, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533565) website on 03 SEP 2014. This report refers to a 11 year old male patient. He was vaccinated with MENVEO (batch number: M13012) intramuscularly in the left arm on 06 JUN 2014 (at 4:45 pm). On 07 JUN 2014, his arm was sore and his left upper arm was red and warm to touch. On 10 JUN 2014, the patient's arm was better except for slight redness. The final outcome of the events reported as recovered. The events reported as non-serious. The causality of the events was not reported.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Hyperhidrosis, Hypoacusis, Pallor, Paraesthesia
Clinical narrative: Case number PHHY2014US111778, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 533818) website on 03 SEP 2014. This report refers to a 15-year-old female patient. Historical conditions and concomitant medication were none. She was vaccinated with MENVEO (batch number M13030 intramuscularly into the left arm, along with GARDASIL (batch number: H020901) intramuscularly into the righ6t arm on 10 JUN 2014. On the same day after vaccination, she could not hear-but was able to follow commands and answer questions. She became pale, diaphoretic and her legs were tingling. At 04:10 she was taken to ER. She walked unassisted from w/c to vehicle. Evaluated at ER for one  hour and 20 min. No medical intervention was made. However, she drank several bottles of water. The final outcome of the events was complete recovery. The events were reported as non-serious, however, the case was internally upgraded as medically significant by the MAH. Causality was not reported.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Vomiting
Clinical narrative: Case number PHHY2014US115567, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 534028) website on 03 SEP 2014. This report refers to a 12  year old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: M11072) IM into left arm on 16 JUN 2015 at 11:05 AM. On the same day she also received GARDASIL (batch number: J013324, other manufacturer) IM into right arm and BOOSTRIX (batch number: E5957, other manufacturer) IM into left arm. Patient was asked to remain in exam room with father for 15 minutes post vaccination. At about 11:10 AM patient's father reported to nurses that patient had started vomiting. Patient was asked to sit in chair and was given a cool cloth for comfort. Physician was made aware and she examined the patient. Patient stated she felt fine at 11:20 AM and left the clinic at 11:25 AM in stable condition accompanied by her father. Post vaccination her blood pressure was 118/76 (within normal range). The final outcome of the event was completely recovered. Seriousness and causality assessment was not reported.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MEN
Symptoms: Activities of daily living impaired, Diplopia, Dizziness, Erythema, Feeling cold
Clinical narrative: Case number PHHY2014US107103, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534187) website received on 27 AUG 2014. This report refers to a 17-year-old female patient. Past medical history includes doxycycline causing rash because of sun exposure. Concomitant medications included amoxicillin for acne and vitamins nos. Vaccination history included pertussis vaccine (unknown manufacturer, batch number: not reported) and experienced high fever. She was vaccinated with meningococcal vaccine (unknown manufacturer, batch number: not reported) along with GARDASIL (batch number: not reported) and hepatitis A vaccine (unknown manufacturer, batch number: not reported) in to the arm on 11 JUN 2014. On 12 JUN 2014, in the afternoon, she had headache, dizziness, tingling and numbness on extremities, 101 fever, muscle aches, totally lethargic (felt like if walked into a door), rapid heartbeat, double vision like when cross eyed. She was given ibuprofen for fever. In the morning she took another ibuprofen got dizzy in school and just wanted to sleep. It was very out of the norm since she usually run 3-4 miles a day. She had fever of 100.7. Symptoms continued, felt like if  heart beat was even faster. On 14 JUN 2014, she had 103.7 fever so she was taken to the emergency room (ER). Blood work revealed low WBC and platelets. She felt extremely hot, sweaty and then really cold. Her face was beet red, even the whites of her eyes were red. She was sent from ER. On 15 JUN 2014, she was feeling better. On 16 JUN 2014, she had low grade fever but had dropping from prior readings. She went to school but picked up by 10:00 AM and she was taken to the doctor for fever reading. She had a body temperature of around 102.7. She underwent Streptococcus coccus throat test and the result was negative. She had no other flu like symptoms. She continues to take fever reducing medicine Tylenol and ibuprofen. Temperature was dropping but she still looks out of it and had a glazed look. The final outcome of the event was condition unchanged. Seriousness and causality was not reported.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MEN
Symptoms: Feeling hot, Glassy eyes, Headache, Heart rate increased, Hyperhidrosis
Clinical narrative: Case number PHHY2014US107103, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534187) website received on 27 AUG 2014. This report refers to a 17-year-old female patient. Past medical history includes doxycycline causing rash because of sun exposure. Concomitant medications included amoxicillin for acne and vitamins nos. Vaccination history included pertussis vaccine (unknown manufacturer, batch number: not reported) and experienced high fever. She was vaccinated with meningococcal vaccine (unknown manufacturer, batch number: not reported) along with GARDASIL (batch number: not reported) and hepatitis A vaccine (unknown manufacturer, batch number: not reported) in to the arm on 11 JUN 2014. On 12 JUN 2014, in the afternoon, she had headache, dizziness, tingling and numbness on extremities, 101 fever, muscle aches, totally lethargic (felt like if walked into a door), rapid heartbeat, double vision like when cross eyed. She was given ibuprofen for fever. In the morning she took another ibuprofen got dizzy in school and just wanted to sleep. It was very out of the norm since she usually run 3-4 miles a day. She had fever of 100.7. Symptoms continued, felt like if  heart beat was even faster. On 14 JUN 2014, she had 103.7 fever so she was taken to the emergency room (ER). Blood work revealed low WBC and platelets. She felt extremely hot, sweaty and then really cold. Her face was beet red, even the whites of her eyes were red. She was sent from ER. On 15 JUN 2014, she was feeling better. On 16 JUN 2014, she had low grade fever but had dropping from prior readings. She went to school but picked up by 10:00 AM and she was taken to the doctor for fever reading. She had a body temperature of around 102.7. She underwent Streptococcus coccus throat test and the result was negative. She had no other flu like symptoms. She continues to take fever reducing medicine Tylenol and ibuprofen. Temperature was dropping but she still looks out of it and had a glazed look. The final outcome of the event was condition unchanged. Seriousness and causality was not reported.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MEN
Symptoms: Hypoaesthesia, Lethargy, Myalgia, Ocular hyperaemia, Paraesthesia
Clinical narrative: Case number PHHY2014US107103, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534187) website received on 27 AUG 2014. This report refers to a 17-year-old female patient. Past medical history includes doxycycline causing rash because of sun exposure. Concomitant medications included amoxicillin for acne and vitamins nos. Vaccination history included pertussis vaccine (unknown manufacturer, batch number: not reported) and experienced high fever. She was vaccinated with meningococcal vaccine (unknown manufacturer, batch number: not reported) along with GARDASIL (batch number: not reported) and hepatitis A vaccine (unknown manufacturer, batch number: not reported) in to the arm on 11 JUN 2014. On 12 JUN 2014, in the afternoon, she had headache, dizziness, tingling and numbness on extremities, 101 fever, muscle aches, totally lethargic (felt like if walked into a door), rapid heartbeat, double vision like when cross eyed. She was given ibuprofen for fever. In the morning she took another ibuprofen got dizzy in school and just wanted to sleep. It was very out of the norm since she usually run 3-4 miles a day. She had fever of 100.7. Symptoms continued, felt like if  heart beat was even faster. On 14 JUN 2014, she had 103.7 fever so she was taken to the emergency room (ER). Blood work revealed low WBC and platelets. She felt extremely hot, sweaty and then really cold. Her face was beet red, even the whites of her eyes were red. She was sent from ER. On 15 JUN 2014, she was feeling better. On 16 JUN 2014, she had low grade fever but had dropping from prior readings. She went to school but picked up by 10:00 AM and she was taken to the doctor for fever reading. She had a body temperature of around 102.7. She underwent Streptococcus coccus throat test and the result was negative. She had no other flu like symptoms. She continues to take fever reducing medicine Tylenol and ibuprofen. Temperature was dropping but she still looks out of it and had a glazed look. The final outcome of the event was condition unchanged. Seriousness and causality was not reported.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MEN
Symptoms: Platelet count decreased, Pyrexia, Somnolence, Streptococcus test negative, White blood cell count decreased
Clinical narrative: Case number PHHY2014US107103, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534187) website received on 27 AUG 2014. This report refers to a 17-year-old female patient. Past medical history includes doxycycline causing rash because of sun exposure. Concomitant medications included amoxicillin for acne and vitamins nos. Vaccination history included pertussis vaccine (unknown manufacturer, batch number: not reported) and experienced high fever. She was vaccinated with meningococcal vaccine (unknown manufacturer, batch number: not reported) along with GARDASIL (batch number: not reported) and hepatitis A vaccine (unknown manufacturer, batch number: not reported) in to the arm on 11 JUN 2014. On 12 JUN 2014, in the afternoon, she had headache, dizziness, tingling and numbness on extremities, 101 fever, muscle aches, totally lethargic (felt like if walked into a door), rapid heartbeat, double vision like when cross eyed. She was given ibuprofen for fever. In the morning she took another ibuprofen got dizzy in school and just wanted to sleep. It was very out of the norm since she usually run 3-4 miles a day. She had fever of 100.7. Symptoms continued, felt like if  heart beat was even faster. On 14 JUN 2014, she had 103.7 fever so she was taken to the emergency room (ER). Blood work revealed low WBC and platelets. She felt extremely hot, sweaty and then really cold. Her face was beet red, even the whites of her eyes were red. She was sent from ER. On 15 JUN 2014, she was feeling better. On 16 JUN 2014, she had low grade fever but had dropping from prior readings. She went to school but picked up by 10:00 AM and she was taken to the doctor for fever reading. She had a body temperature of around 102.7. She underwent Streptococcus coccus throat test and the result was negative. She had no other flu like symptoms. She continues to take fever reducing medicine Tylenol and ibuprofen. Temperature was dropping but she still looks out of it and had a glazed look. The final outcome of the event was condition unchanged. Seriousness and causality was not reported.
Age: 11.0
Sex: M
Vaccine: DTAP, HPV4, MNQ
Symptoms: Rash generalised
Clinical narrative: Case number PHHY2014US113959, is an initial spontaneous report received from the medical assistant via Vaccine Adverse Event Reporting System (VAERS reference number: 534354) website on 03 SEP 2014. This report refers to a 11 year old male patient. He was vaccinated with MENVEO (batch number: not reported) along with 0.5 ml of GARDASIL (other manufacturer, batch number: H017698) intramuscularly and DTAP (other manufacturer, batch number: not reported) on 10 JAN 2014. On 17 JAN 2014, about a week after vaccination the patient experienced rash all over his body. No treatment was given and the outcome of rash all over was reported as recovered on an unspecified date. The event was reported as non-serious. The causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Rash
Clinical narrative: Case number PHHY2014US114880, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534385) website on 03 SEP 2014. This report refers to an 11-year-old female patient. Historical drug included amoxicillin. No concomitant medication was reported. She was vaccinated with MENVEO (batch number: A14022) into the right arm on 19 JUN 2014. At the time of vaccination she underwent skin test with PPD. On the same day within 30 minutes after vaccination, she experienced rash on trunk, arms and legs. No shortness of breath or angioedema. She was given 50 mg Benadryl and was taken to emergency room. Physician stated no further treatment and advised to consult with allergist ASAP. The final outcome of the event was complete recovery. The event was reported as non-serious, however, the case was internally upgraded as medically significant by the MAH. Causality was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Rash, Tuberculin test
Clinical narrative: Case number PHHY2014US114880, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534385) website on 03 SEP 2014. This report refers to an 11-year-old female patient. Historical drug included amoxicillin. No concomitant medication was reported. She was vaccinated with MENVEO (batch number: A14022) into the right arm on 19 JUN 2014. At the time of vaccination she underwent skin test with PPD. On the same day within 30 minutes after vaccination, she experienced rash on trunk, arms and legs. No shortness of breath or angioedema. She was given 50 mg Benadryl and was taken to emergency room. Physician stated no further treatment and advised to consult with allergist ASAP. The final outcome of the event was complete recovery. The event was reported as non-serious, however, the case was internally upgraded as medically significant by the MAH. Causality was not reported.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Tenderness
Clinical narrative: Case number PHHY2014US115204, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 534428) website on 03 SEP 2014. This report refers to a 12 year old female patient. Her medical history included RAD (reactive airway disease). She was vaccinated with MENVEO (batch number: A13030) into left arm on 18 JUN 2014. On an unknown date post vaccination, she experienced swelling from shoulder to base of triceps, very red, and painful to touch. Circled redness noted measured swollen area 4.5 inches top to bottom 2.25 inches side to side. She went to the emergency room. The final outcome of the events was completely recovered. Seriousness and causality assessment was not reported.
Age: 16.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Case number PHHY2014US114881, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 534442) website on 27 AUG 2014. This report refers to a 16-year-old female patient. Past medical history was not reported. Concomitant medication included Junel. The patient was vaccinated with MENVEO (batch number: A14021) and HAVRIX (batch number N434L) both intramuscularly into left arm on 17 JUN 2014. On the same day, post vaccinations, the patient experienced hard at the site of injection. On 18 JUN 2014, the patient experienced redness at the site of injection. On 19 JUN 2014, the patient experienced tenderness and warmth at the site of injection. The patient had a visit to emergency room due to these events. The patient started treatment with cefadroxil antibiotic on 19 JUN 2014. Outcome of the events was reported as condition unchanged as of 19 JUN 2014. Events were reported as non-serious. Causality of the events was not reported.